prostap 6 dcs 30 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe
takeda products ireland ltd - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection in pre-filled syringe - 30 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
decapeptyl 3-month, 11.25 mgpowder and solvent for suspension for injection
ipsen pharmaceuticals limited - triptorelin - powder and solvent for suspension for injection - 11.25 milligram(s) - gonadotropin releasing hormone analogues; triptorelin
decapeptyl 6-month 22.5 mg powder and solvent for prolonged-release suspension for injection
ipsen pharmaceuticals limited - triptorelin pamoate - powder and solvent for prolonged-release suspension for injection - 22.5 milligram(s) - gonadotropin releasing hormone analogues; triptorelin
gonapeptyl depot 3.75mg powder and solvent for suspension for injection
ferring ireland ltd - triptorelin - powder and solvent for suspension for injection - 3.75 milligram(s) - gonadotropin releasing hormone analogues; triptorelin
leuprex 3, 5mg implant
rowex ltd - leuprorelin acetate - implant - 3 mg, 5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
leuprorelin 1-month depot 3.75 mg powder and solvent for prolonged-release suspension for injection
gp-pharm, s.a. - leuprorelin acetate - pdr+solv for pr for susp for inj - 3.75 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
suprecur 150 micrograms/ metered dose nasal spray, solution
sanofi-aventis ireland limited t/a sanofi - buserelin - nasal spray, solution - 150 microgram(s) - gonadotropin releasing hormone analogues; buserelin
leuprorelin 3-month depot 22.5mg powder and solvent for prolonged-release suspension for injection
gp-pharm, s.a. - leuprorelin acetate - pdr+solv for pr for susp for inj - 22.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones - it is indicated for palliative treatment of hormone dependent advanced prostate cancer.
lutrate 1 month depot 3.75 mg powder and solvent for prolonged-release suspension for injection
mercury pharmaceuticals ltd - leuprorelin acetate - powder and solvent for suspension for injection - 3.75 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - it is indicated for palliative treatment of locally advanced or metastatic prostate cancer
lutrate 3 month depot 22.5 mg powder and solvent for prolonged-release suspension for injection
mercury pharmaceuticals ltd - leuprorelin acetate - powder and solvent for suspension for injection - 22.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - it t is indicated for palliative treatment of hormone dependent advanced prostate cancer